I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy of adalimumab as second-line therapy in a pediatri..:
Alvisi P
;
Arrigo S
;
Cucchiara S
...
https://www.dovepress.com/efficacy-of-adalimumab-as-second-line-therapy-in-a-pediatric-cohort-of-peer-reviewed-article-BTT. , 2019
Link:
https://doaj.org/article/d27e38911dc24dcfb8c6197a436c8..
RT Journal T1
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d27e38911dc24dcfb8c6197a436c88cf&Exemplar=1&LAN=DE A1 Alvisi P A1 Arrigo S A1 Cucchiara S A1 Lionetti P A1 Miele E A1 Romano C A1 Ravelli A A1 Knafelz D A1 Martelossi S A1 Guariso G A1 Accomando S A1 Zuin G A1 De Giacomo C A1 Balzani L A1 Gennari M A1 Aloi M PB Dove Medical Press YR 2019 K1 Pediatric Crohn disease K1 Infliximab failure K1 Adalimumab efficacy K1 Adalimumab safety K1 Medicine (General) K1 R5-920 JF https://www.dovepress.com/efficacy-of-adalimumab-as-second-line-therapy-in-a-pediatric-cohort-of-peer-reviewed-article-BTT LK http://dx.doi.org/https://doaj.org/article/d27e38911dc24dcfb8c6197a436c88cf DO https://doaj.org/article/d27e38911dc24dcfb8c6197a436c88cf SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)